B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008365
PubMed Identifier: 32059024
Publication URI: http://europepmc.org/abstract/MED/32059024
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS pathogens
Issue: 2
ISSN: 1553-7366